The world of breast reconstruction over the last several years has seen a dramatic shift in focus to discussion and the application of placing tissue expanders and implants back into the prepectoral space. Although this technique failed during the early advent of breast reconstruction, newer technologies such as advances in fat grafting, improved acellular dermal matrices, better methods of assessing breast flap viability, and enhanced implants appear to have set the stage for the resurgence and positive early results seen with this technique. The main benefits of a switch to prepectoral breast reconstruction clinically appears to be less associated pain, lower incidence of animation deformities, and its associated symptoms as well as presumably better aesthetics. Early data suggest that the results are extremely promising and early adopters have attempted to define the ideal patients for prepectoral breast reconstruction. As with any new operative procedure, an assessment of finances and costs are crucial to its successful implementation. Although current data are minimal, this article attempts to build the fundamentals of an economic model that exhibits and displays potential savings through the use of prepectoral breast reconstruction.
New York, N.Y.
From the Department of Plastic Surgery, Lenox Hill Hospital/Manhattan Eye, Ear, and Throat Hospital, Northwell Health System, Hofstra School of Medicine.
Received for publication July 5, 2017; accepted August 24, 2017.
Disclosure: Dr. Glasberg is a consultant for LifeCell Corp./an Allergan affiliate and Allergan Corp. No compensation or support was received for this article.
Scot Bradley Glasberg, MD, Cosmetic and Reconstructive Plastic Surgery, 42A East 74th Street, New York, NY 10021, firstname.lastname@example.org